Article citationsMore>>

Horn, L.C., Schnurrbusch, U., Bilek, K., Hentschel, B. and Einenkel, J. (2004) Risk of Progression in Complex and Atypical Endometrial Hyperplasia: Clinicopathologic Analysis in Cases with and without Progestogen Treatment. International Journal of Gynecological Cancer, 14, 348-353.
https://doi.org/10.1111/j.1048-891x.2004.014220.x

has been cited by the following article:

• TITLE: Endometrial Hyperplasia with Conservative Treatment Using the Progestin or EP Agents, Compared to Cases that Worsen during Observation

  AUTHORS: Kenji Niwa, Saki Tsurue, Kentaro Niwa, Yoh Hayasaki, Masanori Isobe, Takuji Tanaka

  KEYWORDS: Endometrial Hyperplasia, Progestin, EP, PTEN-Null

  JOURNAL NAME: Open Journal of Pathology, Vol.16 No.1, January 4, 2026

  ABSTRACT: A total of 157 patients were included in this study, comprising 147 with simple Endometrial Hyperplasia (EH) and 10 with complex EH. All patients treated cyclically with progestin or Estrogen-Progestin (EP) exhibited regression of EH after 3 or 4 treatment courses. The relapse rate in patients treated cyclically with progestin was significantly lower than that in those treated with EP for simple EH (P